Artiva Biotherapeutics (ARTV)
Develops cryopreserved allogeneic NK-cell candidates for autoimmune diseases and cancer.
$8.13
vs last close+0.30 (+3.83%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 82.61% | 40.39M shares | |
|---|---|---|---|
| 74 holders · as of Jun 30, 2026 | |||
| Insiders | 3.15% | 1.54M shares | |
| 8 holders · as of Sep 11, 2026 | |||
| Strategic holders | 8.98% | 4.39M shares | |
| 1 holder · as of May 28, 2026 | |||
| Other | 5.26% | 2.57M shares | |
| remainder | |||
48.89M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
74 holders · 40.39M shares · 41 new positions · 66 increased · 2 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 17.96M | 36.73% | +8.10M | Aug 14, 2026 |
| Viking Global Investors LP | 2.60M | 5.33% | +2.60Mnew | Aug 14, 2026 |
| Blackstone Inc. | 2.40M | 4.92% | +2.40Mnew | Aug 14, 2026 |
| 5Am Venture Management, LLC | 2.35M | 4.81% | 0 | Aug 14, 2026 |
| VR Adviser, LLC | 2.04M | 4.18% | +434.0K | Aug 14, 2026 |
| Franklin Resources Inc | 2.00M | 4.09% | +1.48M | Aug 13, 2026 |
| Caligan Partners LP | 1.74M | 3.55% | +1.74Mnew | Aug 14, 2026 |
| Vanguard Capital Management LLC | 981.8K | 2.01% | +774.1K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RA Capital Management, L.P.incl. RA Capital Healthcare Fund, L.P., Peter Kolchinsky +1 more | 37.90% | 18.42M | 13D | Jul 23, 2026 |
| GC Corpincl. Yong-Jun Huh, GC Cell Corporation | 12.30% | 6.00M | 13D | May 28, 2026 |
| Viking Global Investors LP | 5.40% | 2.60M | 13G | May 18, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 8, 2026 | Fred Aslandirector, officer: Chief Executive Officer | Sale | 23,429 | $10.92 | 1,449,765 |
| Sep 3, 2026 | Subhashis Banerjeeofficer: Chief Medical Officer | Sale | 1,100 | $11.16 | 140,947 |
| Sep 3, 2026 | Jennifer Bushofficer: COO, CLO, Compliance Officer | Sale | 8,391 | $11.16 | 329,529 |
| Sep 3, 2026 | Christopher Horanofficer: Chief Tech Operations Officer | Sale | 10,366 | $11.16 | 283,084 |
| Sep 3, 2026 | Fred Aslandirector, officer: Chief Executive Officer | Sale | 61,888 | $11.16 | 1,473,194 |
| Aug 27, 2026 | Subhashis Banerjeeofficer: Chief Medical Officer | Sale | 8,222 | $12.01 | 142,047 |
| Aug 18, 2026 | Subhashis Banerjeeofficer: Chief Medical Officer | Sale | 429 | $12.00 | 144,963 |
| Jul 29, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Purchase | 20,824 | $9.99 | 17,304,626 |
| Jul 31, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Purchase | 24,944 | $9.93 | 17,329,570 |
| Jul 24, 2026 | Ra Capital Management, L.P.director, 10 percent owner: | Purchase | 41,319 | $9.99 | 17,283,802 |
House and Senate disclosures
Not reported.